v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities    
Net income (loss) $ (115,910) $ 26,799
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 19,069 17,824
Goodwill and other long-lived assets impairment 179,526 0
Share-based compensation 4,002 3,320
Equity method investment gain (290) (869)
Deferred income taxes, including change in valuation allowance (42,729) (25)
Change in fair value of contingent consideration 0 25,500
Payment of contingent consideration (48,700) 0
Other, net 803 594
Changes in operating assets and liabilities:    
Receivables, net 21,494 41,699
Inventory (18,191) (19,935)
Prepaid expenses (1,419) (163)
Income taxes payable 7,424 1,442
Accounts payable (8,172) (8,446)
Accrued expenses and other (2,521) 7,689
Federal and state excise taxes payable (3,856) (2,906)
Other, net 610 (74)
Net cash provided by (used in) operating activities (8,860) 92,449
Cash Flows from Investing Activities    
Additions to property, plant, and equipment (14,878) (40,674)
Distributions from equity method investment 1,500 0
Other, net 168 (14)
Net cash used in investing activities (13,210) (40,688)
Cash Flows from Financing Activities    
Payment of dividends and dividend equivalents (7,797) (7,739)
Repurchase of Common Stock (921) (1,035)
Loan fees paid related to borrowings 0 (2,712)
Proceeds from long-term debt 145,000 28,000
Principal payments on long-term debt (56,800) (80,800)
Payment of contingent consideration (62,100) 0
Net cash provided by (used in) financing activities 17,382 (64,286)
Effect of exchange rate changes on cash and cash equivalents (171) 699
Decrease in cash and cash equivalents (4,859) (11,826)
Cash and cash equivalents, beginning of period 18,460 25,273
Cash and cash equivalents, end of period $ 13,601 $ 13,447

Source